A Clinical Trial of Topical Photodynamic Therapy With 5-aminolevulinic Acid for the Treatment of Actinic Keratosis

NCT02799030 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

105

Enrollment

INDUSTRY

Sponsor class

Conditions

Actinic Keratosis

Interventions

DRUG: BF-200 ALA 1%
DRUG: BF-200 ALA 3%
DRUG: BF-200 ALA 10%

Sponsor

Biofrontera Bioscience GmbH